Virtual reality in the treatment of unipolar depressive disorders

Virtual reality in the treatment of unipolar depressive disorders - ViRTUE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00039088

Enrollment

Registered

2026-02-05

Start date

2023-06-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F33.1 F33.2

Interventions

Group 1: The group receives cognitive behavioral therapy over a four-week period (once a week). The content of the four sessions is standardized. Group 2: 1. VR experimental condition (VREnt): Patient

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: F33.1-F33.2

Exclusion criteria

Exclusion criteria: Neurologische Erkrankungen, Erkrankungen des Auges, F0-F2, F3-F32, F5, F6, F7, F8

Design outcomes

Primary

Measure	Time frame
Depression score and scores for dysfunctional thoughts. Endpoints are recorded before the start of therapy (T0) and at the end of therapy (T1). The following questionnaires are used for this purpose: MADRS, QIDS-SR-16, FAG, DAS.	—

Secondary

Measure	Time frame
Inventory for Negative Effects of Psychotherapy (INEP) and general study feedback will be collected at the end of therapy.	—

Countries

Germany

Contacts

Public ContactViola Oertel

Universitätsklinikum Frankfurt am Main

viola.oertel@unimedizin-ffm.de069 63012224

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026